Proton magnetic resonance spectroscopy in mild cognitive impairment and alzheimer's disease: A preliminary study
Background: Mild cognitive impairment (MCI) is recognized as a transitional clinical state between normal aging and Alzheimer's disease (AD) and has significant higher rate of progression to AD. Objective: To compare the changes of metabolites between AD and MCI in specific locations of the bra...
Saved in:
Main Authors: | Wiboon Suriyajakryuththana, Lojana Tuntiyatorn, Nuttika Teepprasarn, Chakrit Sukying |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34500 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Biomarkers of mild cognitive impairment and Alzheimer's disease
by: Tang, B.L., et al.
Published: (2011) -
Screening for mild cognitive impairment and early Alzheimer's disease
by: LI MINGLEI
Published: (2010) -
Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease
by: Qiu, A., et al.
Published: (2014) -
Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment
by: Chua, J., et al.
Published: (2021) -
Clusterin as a blood biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease
by: Panachamnong,N., et al.
Published: (2015)